CURRENT TRIALS

This study is designed to assess a new drug for Irritable Bowel Syndrome with predominant diarrhea. You may qualify to participate in this clinical research study for IBS.

Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women. You may qualify to participate in a clinical research study for Female Sexual Arousal Disorder.

This study is designed to use various methods to determine how Type 1 Diabetes affects the bone structure. You may qualify to participate in a clinical research study for bone health.

Is your knee pain not responding to treatments? You may qualify to participate in a clinical research study of an investigational treatment option for Osteoarthritis.

Are you living with the daily struggle of interstitial cystitis or bladder pain syndrome? We are looking for subjects who are suffering from moderate bladder pain to participate in a research study to investigate a new treatment option.

Can you even count the ways Gout affects your life? It may impact your sleep, your job- even your love life. Right now, Quality Clinical Research is offering a free treatment option for adults diagnosed with Gout ages 19-70. See if you qualify.

The purpose of this study is to evaluate the safety, tolerability, to see if your body develops antibodies to help control celiac disease. Every participant will be required to fast for most appointments and be available for all visits. Participants will also complete 4 1-day gluten challenge tests about every 12 weeks.

The purpose of this study is to see if a new type of shingles vaccine is well tolerated and can help the body make antibodies to help fight off shingles outbreaks in older adults. Every participant will receive two shingles vaccinations. There is no fake shot on this study.

Are you having trouble controlling your blood pressure? We are looking for subjects who are affected by uncontrolled hypertension to participate in a research study to investigate a new treatment option.

QCR has a study for moderate to severe COPD patients, evaluating the efficacy, safety and tolerability of Dupilumab, an investigational biological monoclonal antibody.